Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Shockwave Medical (SWAV)
NASDAQ:SWAV
Shockwave Medical (SWAV) Stock Price & Analysis
674 Followers
SWAV Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$157.00 - $331.58
Previous Close$325.63
Volume814.50K
Average Volume (3M)599.35K
Market Cap
$12.18B
Enterprise Value$11.96B
Total Cash (Recent Filing)$990.55M
Total Debt (Recent Filing)$770.61M
Price to Earnings (P/E)84.3
Beta1.01
Next Earnings
May 06, 2024EPS Estimate
$0.99Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)3.86
Shares Outstanding37,396,816
10 Day Avg. Volume1,055,084
30 Day Avg. Volume599,352
Standard Deviation0.17
R-Squared0.08
Alpha0.04
Financial Highlights & Ratios
Price to Book (P/B)22.50
Price to Sales (P/S)16.68
Price to Cash Flow (P/CF)42.10
P/FCF Ratio45.70
Enterprise Value/Market CapN/A
Enterprise Value/Revenue16.38
Enterprise Value/Gross Profit18.84
Enterprise Value/Ebitda64.90
Forecast
1Y Price Target
$266.71Price Target Upside-18.09% Downside
Rating ConsensusModerate Buy
Number of Analyst Covering9
Shockwave Medical News
PremiumCompany Announcements
Shockwave Medical Merges with Johnson & Johnson, Retains Key Leader
Ownership Overview
Currently, No data available
---
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
The estimated number of people who visited one or more of the websites owned by Shockwave Medical
Desktop Users
Mobile Users
SWAV FAQ
What was Shockwave Medical’s price range in the past 12 months?
Shockwave Medical lowest stock price was $157.00 and its highest was $331.58 in the past 12 months.
What is Shockwave Medical’s market cap?
Currently, no data Available
When is Shockwave Medical’s upcoming earnings report date?
Shockwave Medical’s upcoming earnings report date is May 06, 2024 which is in 16 days.
How were Shockwave Medical’s earnings last quarter?
Shockwave Medical released its earnings results on Feb 15, 2024. The company reported $1.16 earnings per share for the quarter, beating the consensus estimate of $0.89 by $0.27.
Is Shockwave Medical overvalued?
According to Wall Street analysts Shockwave Medical’s price is currently Overvalued.
Does Shockwave Medical pay dividends?
Shockwave Medical does not currently pay dividends.
What is Shockwave Medical’s EPS estimate?
Shockwave Medical’s EPS estimate is $0.99.
How many shares outstanding does Shockwave Medical have?
Shockwave Medical has 37,396,816 shares outstanding.
What happened to Shockwave Medical’s price movement after its last earnings report?
Shockwave Medical reported an EPS of $1.16 in its last earnings report, beating expectations of $0.89. Following the earnings report the stock price went up 11.146%.
Which hedge fund is a major shareholder of Shockwave Medical?
Among the largest hedge funds holding Shockwave Medical’s share is Gilder Gagnon Howe & Co LLC.. It holds Shockwave Medical’s shares valued at 102M.
---
Shockwave Medical Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$266.71 (-18.09% Downside)
$266.71 (-18.09% Downside)
Blogger Sentiment
Bullish
SWAV Sentiment 91%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Decreased
By 25.4K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $15.4M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Neutral
Last 7 Days ▼ 0.2%
Last 30 Days ▼ 0.2%
Last 30 Days ▼ 0.2%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
51.32%
12-Months-Change
Fundamentals
Return on Equity
24.96%
Trailing 12-Months
Asset Growth
138.31%
Trailing 12-Months
Company Description
Shockwave Medical
Shockwave Medical, Inc. operates as a medical device company. It focuses on developing and commercializing products intended to transform the way calcified cardiovascular disease is treated. The firm offers M5 catheters for treating above-the-knee peripheral artery disease; C2 catheters for treating coronary artery disease; and S4 catheters or treating below-the-knee peripheral artery disease. The company was founded by Daniel Hawkins, John M. Adams, and Todd J. Brinton in 2009 and is headquartered in Santa Clara, CA.
---
SWAV Earnings Call
Q4 2024
0:00 / 0:00
---
SWAV Stock 12 Months Forecast
Average Price Target
$266.71
▼(-18.09% Downside)
Technical Analysis
Best Analysts Covering SWAV
1 Year
1 Year Success Rate
16/17 ratings generated profit
1 Year Average Return
+49.62%
reiterated a buy rating 2 months ago
Copying William Plovanic's trades and holding each position for 1 Year would result in 94.12% of your transactions generating a profit, with an average return of +49.62% per trade.
---